Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
Brain Protection and Neurological Prognosis in Patients With Heart Valve Disease Undergoing Cardiopulmonary Bypass Operation
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to clarify the changes of neurocognitive function of patients undergoing cardiac valve disease before and after surgical treatment under cardiopulmonary bypass operation, and to predict the neurological prognosis of such patients through combined imaging technology, so as to improve and avoid the occurrence of postoperative neurological dysfunction in such patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2022
CompletedStudy Start
First participant enrolled
September 10, 2022
CompletedFirst Posted
Study publicly available on registry
September 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 14, 2022
September 1, 2022
3.3 years
September 5, 2022
September 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of brain volume before and after operation
The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.
before operation; 7-10 Days after operation; 1 month; 6-12months
Change of brain function connectivity before and after operation
The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.
before operation; 7-10 Days after operation; 1 month; 6-12months
Secondary Outcomes (10)
Change of brain evaluate basic cognition before and after operation
before operation; 7-10 Days after operation; 1 month; 6-12months
Change of executive functions before and after operation evaluated by Trail-Making Test Part A
before operation; 7-10 Days after operation; 1 month; 6-12months
Change of executive functions before and after operation evaluated by Digit Symbol Coding score
before operation; 7-10 Days after operation; 1 month; 6-12months
Change of working memory before and after operation evaluated by Forward Digit Span
before operation; 7-10 Days after operation; 1 month; 6-12months
Change of working memory before and after operation evaluated by Backward Digit Span
before operation; 7-10 Days after operation; 1 month; 6-12months
- +5 more secondary outcomes
Study Arms (2)
HVD
Heart Valve Disease
HC
Healthy controls
Interventions
Eligibility Criteria
All of the patients of HVD group are in-patients and out-patients in the cardiac surgery department from the research center. The subjects of control group are recruited from community.
You may qualify if:
- Aged 45-80 years old.
- Accept heart biological valve replacement or heart valvuloplasty.
- More than 6 years of Education.
- At baseline, the score of Mini-mental State Examination (MMSE) scale is more than 23 points
You may not qualify if:
- Patients who failed to obtain informed consent.
- Preoperative diagnosis of stroke, epilepsy, history of craniocerebral surgery, cerebrovascular disease, psychosis and rescue patients with cardiopulmonary resuscitation before operation.
- Alcoholism, illiteracy and left-handed.
- There was severe organ hypoperfusion or organ dysfunction before operation, including: preoperative myocardial infarction \< 90 days, renal failure or dialysis, severe liver injury, digestive tract ischemia, spinal cord ischemia and iliac artery occlusion.
- There are contraindications to magnetic resonance examination, such as claustrophobia and metal implants in the body.
- Pregnant or lactating women.
- Participating in other clinical studies will affect the main indicators of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nanjing University of Traditional Chinese Medicinelead
- Xi'an Jiaotong Universitycollaborator
- Yuncheng First Hospitalcollaborator
Study Sites (1)
Yuncheng First Hospital
Yuncheng, Shanxi, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nengrui Guo
Yuncheng First Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investgator
Study Record Dates
First Submitted
September 5, 2022
First Posted
September 14, 2022
Study Start
September 10, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 14, 2022
Record last verified: 2022-09